Pricing Log in Create free account
Friday 6 November 2026 Export HLN’s income statement to Excel — free account

Haleon PLC Sponsored ADR

HLN Healthcare Drug Manufacturers Specialty & Generic

Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.

9.13 0.10 −1.08%
Market cap
$40.2B
P/E
20.5×
Fwd P/E
16.5×
Dividend yield
2.16%
F-score
8/9
Altman Z
3.04
Beneish M
−2.60
Dividend safety
63/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Haleon PLC Sponsored ADR (HLN) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Haleon PLC Sponsored ADR (HLN) trades at a P/B ratio of 1.9×. Over the past ten years it has ranged from 0.0× (March 2023) to 2.5× (June 2025); the current reading is higher than 41% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 1.8× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 2.2× 4.58%
FY2024 2.1× 13.55%
FY2023 1.8× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period P/B ratio Change
Sep 2024 2.3× 24.80%
Mar 2024 1.8× 0.42%
Sep 2023 1.8× (1.31%)
Jun 2023 1.9× 0.74%
1 more quarters

Against its own ten years

Low 0.0× High 2.5×
Ten-year median 2.0×
Current reading's percentile 30

P/B ratio against peers

Company P/B ratio
TAK Takeda Pharmaceutical Co. compare 1.4×
VTRS Viatris Inc. compare 1.6×
ELAN Elanco Animal Health Incorporated compare 1.8×
HLN Haleon PLC Sponsored ADR 1.9×
RDY Dr. Reddy's Laboratories Ltd compare 3.0×
UTHR United Therapeutics Corporation compare 3.8×
NBIX Neurocrine Biosciences, Inc. compare 4.2×
TEVA Teva Pharmaceutical Industries Ltd. compare 6.1×
ZTS Zoetis Inc. compare 10.8×
Drug Manufacturers Specialty & Generic industry median 1.8×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on HLN